Roridin A

CAS: 14729-29-4

Ref. 3D-FR171536

Produktinformation

• Name: Roridin A
• Synonyme: (10Z,12Z)-4-hydroxy-9-(1-hydroxyethyl)-5,16a,21-trimethyl-4,5,6,7,16,16a,22,23-octahydro-3H,18H,19aH-spiro[16,18-methano[1,6,12]trioxacyclooctadecino[3,4-d]chromene-17,2'-oxirane]-3,14(9H)-dione, (4S,5R,9R,10E,12Z,16R,16aS,18R,19aR,23aR)-4-hydroxy-9-[(1R)-1-hydroxyethyl]-5,16a,21-trimethyl-4,5,6,7,16,16a,22,23-octahydro-3H,18H,19aH-spiro[16,18-methano[1,6,12]trioxacyclooctadecino[3,4-d]chromene-17,2'-oxirane]-3,14(9H)-dione, (4S,5R,9R,10Z,12Z,16R,16aS,17R,18R,19aR,23aR)-4-hydroxy-9-[(1R)-1-hydroxyethyl]-5,16a,21-trimethyl-4,5,6,7,16,16a,22,23-octahydro-3H,18H,19aH-spiro[16,18-methano[1,6,12]trioxacyclooctadecino[3,4-d]chromene-17,2'-oxirane]-3,14(9H)-dione, (7′R)-7′-Deoxo-7′-[(1R)-1-hydroxyethyl]verrucarin A, Ai3-29708, Nsc 200737, Roridan A, Roridine A, Spiro[16,18-methano-1H,3H,23H-[1,6,12]trioxacyclooctadecino[3,4-d][1]benzopyran-17(18H),2′-oxirane], verrucarin A deriv., Verrucarin A, 7'-deoxo-7'-((1R)-1-hydroxyethyl)-, (7'R)-, Verrucarin A, 7'-deoxo-7'-(1-hydroxyethyl)-, Verrucarin A, 7'-deoxo-7'-(1-hydroxyethyl)-, (7'R(R))-, Verrucarin A, 7′-deoxo-7′-(1-hydroxyethyl)-, [7′R(R)]-, Verrucarin A, 7′-deoxo-7′-[(1R)-1-hydroxyethyl]-, (7′R)-

Beschreibung

Roridin A is a cyclic peptide that has been shown to induce apoptosis in human macrophages and HL-60 cells. It also inhibits the production of vascular endothelial growth factor (VEGF) by human monocytes and lymphocytes, as well as inducing the differentiation of CD-1 mice. Roridin A binds to a death protein, which then activates caspases, leading to cell death. This compound can be used for diagnosis and treatment of cancer, autoimmune diseases, and infectious diseases.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 532.62 g/mol
• Formel: C₂₉H₄₀O₉
• Reinheit: Min. 95%